 NASHVILLE, Tenn., June 14, 2021 GLOBE NEWSWIRE -- Harrow Health, Inc. NASDAQ: HROW Harrow Health or the Company, an ophthalmic-focused healthcare company, today announced the pricing of its underwritten registered public offering of 17.5 million aggregate principal amount of 8.625 senior notes due 2026 the Notes. The Company has granted the underwriters a 30-day option to purchase an additional 2.5 million aggregate principal amount of Notes in connection with the offering. The Notes will be treated as a single series with the Companys outstanding 8.625 senior notes due 2026 and will trade interchangeably with the existing notes. The Notes will be sold to investors at a price of 25.75 per Note, for aggregate gross proceeds of 18,025,000. The offering is expected to close on June 17, 2021, subject to customary closing conditions. 